1-5 of 5
Alfred Morgenstern
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer

Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, Vicky Caveliers, Peter Covens, Brian W. Miller, Matthijs B. Sevenois, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte, Matthias D'Huyvetter, Marek Pruszyński
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (12): 1835–1845.
https://doi.org/10.1158/1535-7163.MCT-21-1021
Published: 02 December 2022
View article titled, Preclinical Evaluation of <sup>225</sup>Ac-Labeled Single-Domain Antibody for the Treatment of HER2<sup>pos</sup> Cancer
Open the PDF for Preclinical Evaluation of <sup>225</sup>Ac-Labeled Single-Domain Antibody for the Treatment of HER2<sup>pos</sup> Cancer in another window
Includes: Supplementary data
Journal Articles

The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy

Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, Sam Vander Meeren, Wim Renmans, Karel Fostier, Pieterjan Debie, Heleen Hanssens, Magdalena Rodak, Marek Pruszynski, Kim De Veirman, Karin Vanderkerken, Tony Lahoutte, Alfred Morgenstern, Frank Bruchertseifer, Nick Devoogdt, Matthias D'Huyvetter
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (1): 159–169.
https://doi.org/10.1158/1535-7163.MCT-21-0220
Published: 01 January 2022
View article titled, The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy
Open the PDF for The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy in another window
Includes: Supplementary data
Journal Articles

Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues

Charles Zhu, Amey Bandekar, Michelle Sempkowski, Sangeeta Ray Banerjee, Martin G. Pomper, Frank Bruchertseifer, Alfred Morgenstern, Stavroula Sofou
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (1): 106–113.
https://doi.org/10.1158/1535-7163.MCT-15-0207
Published: 07 January 2016
View article titled, Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues
Open the PDF for Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues in another window
Includes: Supplementary data
Journal Articles

Targeting Aberrant DNA Double-Strand Break Repair in Triple-Negative Breast Cancer with Alpha-Particle Emitter Radiolabeled Anti-EGFR Antibody

Hong Song, Mohammad Hedayati, Robert F. Hobbs, Chunbo Shao, Frank Bruchertseifer, Alfred Morgenstern, Theodore L. DeWeese, George Sgouros
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2013) 12 (10): 2043–2054.
https://doi.org/10.1158/1535-7163.MCT-13-0108
Published: 07 October 2013
View article titled, Targeting Aberrant DNA Double-Strand Break Repair in Triple-Negative Breast Cancer with Alpha-Particle Emitter Radiolabeled Anti-EGFR Antibody
Open the PDF for Targeting Aberrant DNA Double-Strand Break Repair in Triple-Negative Breast Cancer with Alpha-Particle Emitter Radiolabeled Anti-EGFR Antibody in another window
Journal Articles

213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe

Christof Seidl, Matthias Port, Klaus-Peter Gilbertz, Alfred Morgenstern, Frank Bruchertseifer, Markus Schwaiger, Barbara Röper, Reingard Senekowitsch-Schmidtke, Michael Abend
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (8): 2346–2359.
https://doi.org/10.1158/1535-7163.MCT-07-0132
Published: 15 August 2007
View article titled, <sup>213</sup>Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G<sub>2</sub> arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe
Open the PDF for <sup>213</sup>Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G<sub>2</sub> arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe in another window